Abstract
Introduction Relugolix is the first oral gonadotrophin-releasing hormone (GnRH) receptor antagonist. Based on the phase III HERO trial results, relugo......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
